Roberta Brinton at NIH for Research Talk
March 2, 2009 10:48 AM
How do you transition basic science discoveries made at the bench to the bedside? The answer is called phase 1 translational research, and it was the subject of a discussion led by Roberta Diaz Brinton of the USC School of Pharmacy at a National Center for Research Resources workshop at the National Institutes of Health on Feb. 10.
“Remarkably, a consistent barrier across many universities is the translation of discovery into the business sector,” Brinton said. “I was surprised at how ubiquitous this barrier is across almost every university that was represented at the workshop. This is clearly an opportunity for the USC Stevens Institute to take a lead position - but it must be in the biomedical arena for relevance to NIH investment in biomedical research.”
In attendance were top officials of the National Institute on Aging and the Food and Drug Administration, staff members from NIH institutes and 200 participants from universities and industry.
Brinton is a professor of pharmacology and pharmaceutical sciences and biomedical engineering.
TAGS: research
Latest Capital Connections stories
- Holly Goes for Impact at D.C. Briefing November 16, 2009 11:00 AM
- Buffington Targets TV's Health Stories October 30, 2009 1:00 PM
- SPPD Dean Visits Capitol Hill October 23, 2009 1:24 PM
-
For Journalists »
-
-
Other News around USC
- Capital Connections
- USC faculty, staff and alumni in Washington, D.C., and Sacramento
- In Print
- New and recent books written or edited by USC faculty and staff
- Family Matters
- Achievements and awards
- Obituaries